| dc.contributor.author | Endah Puspitasari | |
| dc.contributor.author | Evi Umayah Ulfa | |
| dc.contributor.author | Vita Ariati | |
| dc.contributor.author | Mohammad Sulthon Habibi | |
| dc.date.accessioned | 2016-10-24T00:54:09Z | |
| dc.date.available | 2016-10-24T00:54:09Z | |
| dc.date.issued | 2016-10-24 | |
| dc.identifier.isbn | 978-602 | |
| dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/77241 | |
| dc.description | PROCEEDIMG The 1st International Conference: on pharmaceutics & pharmaceutical sciences
Drug Deiivery Systems:
From Drug-Discovery, Pre-formulaticn, Formulation and Technological Approaches for
Poorly Soluble Drugs and Protein | en_US |
| dc.description.abstract | Fifteen rats were devided into three groups. Group I as control, received CMC Na 1 %.
Group ll received EEAfL 500 mC/kC BW Group lll received EEAfL 1,500 mglkg BW The treatment was done orally for 11 days. At the 12th day, the blood sample was collected and analyzed further for leukocytes and lymphocytes cell count. | en_US |
| dc.language.iso | en | en_US |
| dc.subject | ARCANGELISIA FLAVA | en_US |
| dc.subject | RATS' LYMPHOCYTE | en_US |
| dc.title | Arcangelisia Flava Increases Rats' Leukocytes but has Biphasic Effect on Rats' Lymphocyte | en_US |
| dc.type | Prosiding | en_US |
